J DermatolRCT
Investigation of the Efficacy and Safety of TO-208 in Patients 2 Years of Age or Older With Molluscum Contagiosum in Japan
A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Study (208-3-1) and Its Open-Label Extension.
From the abstractOverall, TO-208 was significantly superior to the placebo in achieving complete clearance of MC lesions at the end of the study visit and was generally well tolerated, with adverse events that were predominantly mild to moderate in severity and limited to application sites. Trial Registration: Japan Registry of Clinical Trials: jRCT2041220039.
Kadono T, Mitsuishi T, … senior author Igarashi AJournal of Dermatology